Amgen Inc. is at least fairly valued, with improving balance sheet metrics and a robust growth pipeline offsetting looming ...

The Small Business Administration (SBA) has commenced its promised “full-scale audit” of the 8(a) Business Development ...

The accounting cycle tracks a transaction until it's added to your company's financial statement. Follow this eight-step ...

Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

Dragonfly Energy Holdings has seen its price target narrative sharpen, with fair value holding steady at $1.88 per share while a slightly lower discount rate signals improved confidence in the ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The latest update is out from Dyne Therapeutics ( (DYN) ).

Robert Fantasiza, his wife Cheryl and their two sons, one of whom is believed to be incarcerated, are all named in the ...

The strategic use of certain ETFs can help investors turn unrealized stock-picking losses into tangible tax savings.

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies ...

On December 5, the Small Business Administration (“SBA”) circulated a letter to all 8(a) businesses demanding verification of eligibility under ...

Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...